| Thrombectomy for stroke at 6 to 16 hours with selection by perfusion imaging GW Albers, MP Marks, S Kemp, S Christensen, JP Tsai, ... New England Journal of Medicine 378 (8), 708-718, 2018 | 3735 | 2018 |
| Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute ischaemic stroke: a meta-analysis of individual patient … J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ... The Lancet 384 (9958), 1929-1935, 2014 | 2351 | 2014 |
| Magnetic resonance imaging profiles predict clinical response to early reperfusion: the diffusion and perfusion imaging evaluation for understanding stroke evolution (DEFUSE) study GW Albers, VN Thijs, L Wechsler, S Kemp, G Schlaug, E Skalabrin, ... Annals of Neurology: Official Journal of the American Neurological …, 2006 | 1434 | 2006 |
| MRI profile and response to endovascular reperfusion after stroke (DEFUSE 2): a prospective cohort study MG Lansberg, M Straka, S Kemp, M Mlynash, LR Wechsler, TG Jovin, ... The Lancet Neurology 11 (10), 860-867, 2012 | 837 | 2012 |
| Primary and secondary prevention of cardiovascular disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians evidence-based clinical … PO Vandvik, AM Lincoff, JM Gore, DD Gutterman, FA Sonnenberg, ... Chest 141 (2), e637S-e668S, 2012 | 685 | 2012 |
| Antithrombotic and thrombolytic therapy for ischemic stroke: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical … MG Lansberg, MJ O'Donnell, P Khatri, ES Lang, MN Nguyen-Huynh, ... Chest 141 (2), e601S-e636S, 2012 | 627 | 2012 |
| Stroke Thrombolysis Trialists’ Collaborative Group. Effect of treatment delay, age, and stroke severity on the effects of intravenous thrombolysis with alteplase for acute … J Emberson, KR Lees, P Lyden, L Blackwell, G Albers, E Bluhmki, T Brott, ... Lancet 384 (9958), 1929-1935, 2014 | 439 | 2014 |
| MRI abnormalities associated with partial status epilepticus MG Lansberg, MW O’Brien, AM Norbash, ME Moseley, M Morrell, ... Neurology 52 (5), 1021-1021, 1999 | 421 | 1999 |
| Optimal Tmax threshold for predicting penumbral tissue in acute stroke JM Olivot, M Mlynash, VN Thijs, S Kemp, MG Lansberg, L Wechsler, ... Stroke 40 (2), 469-475, 2009 | 409 | 2009 |
| Evolution of apparent diffusion coefficient, diffusion-weighted, and T2-weighted signal intensity of acute stroke MG Lansberg, VN Thijs, MW O'Brien, JO Ali, AJ de Crespigny, DC Tong, ... American Journal of Neuroradiology 22 (4), 637-644, 2001 | 377 | 2001 |
| Comparison of diffusion-weighted MRI and CT in acute stroke MG Lansberg, GW Albers, C Beaulieu, MP Marks Neurology 54 (8), 1557-1561, 2000 | 334 | 2000 |
| Efficacy and safety of tissue plasminogen activator 3 to 4.5 hours after acute ischemic stroke: a metaanalysis MG Lansberg, E Bluhmki, VN Thijs Stroke 40 (7), 2438-2441, 2009 | 332 | 2009 |
| Antithrombotic therapy in peripheral artery disease: antithrombotic therapy and prevention of thrombosis: American College of Chest Physicians Evidence-Based Clinical Practice … P Alonso-Coello, S Bellmunt, C McGorrian, SS Anand, R Guzman, ... Chest 141 (2), e669S-e690S, 2012 | 314 | 2012 |
| Risk factors of symptomatic intracerebral hemorrhage after tPA therapy for acute stroke MG Lansberg, VN Thijs, R Bammer, S Kemp, CAC Wijman, MP Marks, ... Stroke 38 (8), 2275-2278, 2007 | 294 | 2007 |
| Symptomatic intracerebral hemorrhage following thrombolytic therapy for acute ischemic stroke: a review of the risk factors MG Lansberg, GW Albers, CAC Wijman Cerebrovascular diseases 24 (1), 1-10, 2007 | 280 | 2007 |
| A multicenter randomized controlled trial of endovascular therapy following imaging evaluation for ischemic stroke (DEFUSE 3) GW Albers, MG Lansberg, S Kemp, JP Tsai, P Lavori, S Christensen, ... International Journal of Stroke 12 (8), 896-905, 2017 | 274 | 2017 |
| Is early ischemic lesion volume on diffusion-weighted imaging an independent predictor of stroke outcome? A multivariable analysis VN Thijs, MG Lansberg, C Beaulieu, MP Marks, ME Moseley, GW Albers Stroke 31 (11), 2597-2602, 2000 | 271 | 2000 |
| RAPID automated patient selection for reperfusion therapy: a pooled analysis of the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET) and the Diffusion and Perfusion … MG Lansberg, J Lee, S Christensen, M Straka, DA De Silva, M Mlynash, ... Stroke 42 (6), 1608-1614, 2011 | 258 | 2011 |
| Treatment time-specific number needed to treat estimates for tissue plasminogen activator therapy in acute stroke based on shifts over the entire range of the modified Rankin Scale MG Lansberg, M Schrooten, E Bluhmki, VN Thijs, JL Saver Stroke 40 (6), 2079-2084, 2009 | 242 | 2009 |
| Risk for symptomatic intracerebral hemorrhage after thrombolysis assessed by diffusion‐weighted magnetic resonance imaging OC Singer, MC Humpich, J Fiehler, GW Albers, MG Lansberg, A Kastrup, ... Annals of Neurology: Official Journal of the American Neurological …, 2008 | 225 | 2008 |
Greg ZaharchukStanford UniversityVerified email at stanford.edu
